Session Details
[2O07m-2]Dementia 2
Wed. Aug 2, 2023 9:45 AM - 10:45 AM JST
Wed. Aug 2, 2023 12:45 AM - 1:45 AM UTC
Wed. Aug 2, 2023 12:45 AM - 1:45 AM UTC
Room 7 Shirakashi 2
Chair: Taisuke Tomita (Graduate School of Pharmaceutical Sciences, The University of Tokyo), Makoto Higuchi (National Institutes for Quantum Science and Technology)
[2O07m-2-01]Establishment of the In Vitro Models of Alzheimer’s Disease Patients Using iPSCs and the Evaluation of Sex Hormone’s Effects
○Sopak Supakul1, Sumihiro Maeda1, Hideyuki Okano1 (1. Sch Med, Keio Univ, Tokyo, Japan)
[2O07m-2-02]Beta-alanyl-3-methyl-L-histidine prevents tau-mediated neurodegeneration and cognitive decline by inhibiting astrocytes activation via NF-kB signaling pathway
○CHENXU LEI1, Tatsuhiro Hisatsune1 (1. Graduate School of Frontier Sciences, The University of Tokyo)
[2O07m-2-03]Analyses of Apolipoprotein E Christchurch variant of iPS cell-derived astrocytes in Alzheimer's disease
○Rei Murakami1, Hirotaka Watanabe1, Hideyuki Okano1 (1. Keio University School of Medicine, Tokyo, Japan)
[2O07m-2-04]Neuroinflammatory and cognitive profiles with aging in a transgenic model of Alzheimer’s disease
○AVIJIT BANIK1,2, Thota Ganesh2 (1. Current address: Department of Biotechnology, School of Science, GITAM (Deemed to be) University, Visakhapatnam, AP, 530025, India, 2. Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, 30322, USA)